Reply to “Double-Carbapenem Therapy Not Proven To Be More Active than Carbapenem Monotherapy against KPC-Positive Klebsiella pneumoniae”

Benzer Materyaller

• Double-Carbapenem Therapy Not Proven To Be More Active than Carbapenem Monotherapy against KPC-Positive Klebsiella pneumoniae
  Yazar:: Thomson, Kenneth S.
  Baskı/Yayın Bilgisi: (2012)
• Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae
  Yazar:: Bulik, Catharine C., ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Emergence of KPC-2 and KPC-3 in Carbapenem-Resistant Klebsiella pneumoniae Strains in an Israeli Hospital
  Yazar:: Leavitt, Azita, ve diğerleri
  Baskı/Yayın Bilgisi: (2007)
• The Carbapenemase-Producing Klebsiella pneumoniae Population Is Distinct and More Clonal than the Carbapenem-Susceptible Population
  Yazar:: Esteban-Cantos, Andrés, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae
  Yazar:: Landman, David, ve diğerleri
  Baskı/Yayın Bilgisi: (2009)